3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
CNS
1
Conditions
Thrombocytopenia
1
Pyruvate Kinase Deficiency of Red Cells
1
Polycystic Kidney, Autosomal Recessive
1
Neurofibromatosis-Noonan syndrome
1
Neurofibromatoses
1
Myotonic Dystrophy
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Muscular Dystrophy, Duchenne
1
Leukemia, Myeloid, Acute
1
Hydrocephalus, X-linked
1
Huntington Disease
1
Hemophilia B
1
Hemophilia A
1
Hematologic Neoplasms
1
Fragile X Syndrome
1
Cystic Fibrosis
1
Anemia, Sickle Cell
1
Anemia, Hemolytic, Congenital
1
Anemia, Hemolytic
1
Interventions
emicizumab
4
Factor VIII
2
ziprasidone
1
recombinant FVIIa
1
anti-inhibitor coagulant complex
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Deamino Arginine Vasopressin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemophilia A
×
Blood Specimen Collection
×
Classical hematology
×
Clear all
NCT06147414
2026-04-23
DANNIgene
Assistance Publique - Hôpitaux de Paris
Recruiting
550 enrolled